Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma
JAMA 2020 Nov 17;324(19)1957-1969, SH AlDubayan, JR Conway, SY Camp, L Witkowski, E Kofman, B Reardon, S Han, N Moore, H Elmarakeby, K Salari, H Choudhry, AM Al-Rubaish, AA Al-Sulaiman, AK Al-Ali, A Taylor-Weiner, EM Van AllenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.